Eliminating Biofilm & Biofouling
Without Toxic Chemicals

Nature-inspired peptide technology that prevents biofilm formation across desalination, cooling towers, maritime and industrial systems.

BACKGROUND

Biofilm & Biofouling

In a wet environment

Microbes

Single cell organisms settle on hard surfaces in water

Biofilm

Microbes form a slime layer that aids surface attachment and survival

Biofouling

Other organisms, plants and algae attach to biofilms, grow and create a community

The Global Problem

Biofilm and Biofouling
costs global industries
over $100B annually.

Energy Waste

+20% energy consumption
Increased operational costs

Operational Downtime

Frequent cleaning
Membrane replacement
Equipment damage

Biofouling

Toxic chemicals
Anti-microbial resistance
Regulatory pressure

Our Solution

We Mimic Nature’s 600M-Year Biofilm Defense.
Also about IP peptide protected technology.

Actinia Equina

Sea anemone

Eqt2 II Natural Protein

Triggers microbial dispersion, preventing and treating biofilm

Synthetic Eqt2Z Peptide

Engineered, stable peptide replicating the signaling function that is non-toxic.

MECHANISM OF ACTION

Triggering the Natural Dispersal Phase of the Microbial Life Cycle

Microbial life cycle: attachment to dispersal

Water Treatment

Solving Biofilm in Pipes, Desalination Plants, Cooling Towers, and Industrial Water Systems

Maritime

Eliminating Biofilm and Biofouling in Ships, Underwater Equipment, Ballast Water Tanks, Pipelines, and Onboard Desalination Systems

Competitive Advantage

EXISTING SOLUTIONS
Chemicals
Toxic, limited efficiency
Physical Cleaning
Expensive, repetitive, limited durability, downtime
Coatings
Degrade, limited durability, costly, dry docking – downtime
Ultrasonics

Partial, inconsistent
effectiveness

Extreme potency enables massive scalability

Desalination Plants

Desalination Plants
244grams


Protects a mid-size SWRO for one year

Container Ships

Container Ships
18grams


Protects an entire container ship

Deployment

Water dosing
Paint & coating additive

Manufacturing

Scalable synthesis ready

Zero Friction

No infrastructure or
workflow changes

Results

90% Reduction

in biofilm on desalination membranes over a 20-day trial

90% Lower

electricity use related to biofilm management through reduced pressure

78% Cost Savings

Over traditional chlorine treatments in desalination plants

$4M Savings

Annual fuel savings potential per large vessel for maritime applications

Target Markets

Water Treatment

Desalination
Biofilm impact
  • Up to 30% OPEX
  • +20% energy use
  • Downtime
  • Membrane damage

Water Treatment

Cooling Towers
Biofilm impact
  • High cost
  • Downtime
  • Heavy chemical use

Maritime

Shipping
Biofouling impact
  • +25% fuel burn
  • Downtime
  • Ocean toxicity

2 pilots planned
Singapore & Israel

Started with a global
partner – 2 labs testing

Started a 2-phase navy
test (sticky peptide)

About

DisperseBio engineers protein-based solutions for one of industry’s oldest and most costly challenges: biofilm, a problem estimated to cost over $100 billion annually.

Our peptide platform is built on years of research into how marine organisms naturally control microbial communities – without killing them.

We replace toxic anti-foulants with biology that is safer, smarter, more sustainable, and cost-effective. By targeting the signals that drive biofilm formation, our technology prevents fouling before it starts, reducing chemical use while improving operational performance.

We believe the future of industrial protection lies in working with nature, not against it.

Our Investors

Team

Ori Choshen | CEO

Serial entrepreneur and investor with a track record of building and scaling deep-tech ventures. Formerly led VLX Ventures, with senior business development roles at SanDisk, M-Systems, and Orange. Brings strong expertise in commercialization, partnerships, and taking technologies from concept to market in heavy regulated markets.

Dr. Amir Zlotkin | Founder, CTO
Dr. Amir Zlotkin | Founder, CTO

Microbiologist and inventor of DisperseBio’s technology. Led Infectious Disease Research at Sheba Medical Center and served as CSO at Hutchinson Water, pivoting clinical expertise into water treatment innovation.

Sarit Arazi
Sarit Arazi | CFO

CFO with 20+ years of experience leading financial strategy, operations, and execution across startups and global companies. Extensive experience in IPO readiness, M&A, and venture capital, with deep expertise in DeepTech and MedTech, enabling scalable growth and disciplined financial management.

Contact

    Scroll to Top

    Book a Pilot

    Fill out the form below, and we will be in touch shortly.